We are live on ! Find out more
HIMS icon

Hims & Hers Health

156 hedge funds and large institutions have $682M invested in Hims & Hers Health in 2022 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 50 increasing their positions, 42 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

239% more call options, than puts

Call options by funds: $9.89M | Put options by funds: $2.91M

27% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 22

19% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 42

6% more capital invested

Capital invested by funds: $643M → $682M (+$38.4M)

1% more funds holding

Funds holding: 154156 (+2)

4.94% less ownership

Funds ownership: 58%53.06% (-4.9%)

38% less funds holding in top 10

Funds holding in top 10: 85 (-3)

Holders
156
Holders Change
+2
Holders Change %
+1.3%
% of All Funds
2.51%
Holding in Top 10
5
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-37.5%
% of All Funds
0.08%
New
28
Increased
50
Reduced
42
Closed
22
Calls
$9.89M
Puts
$2.91M
Net Calls
+$6.98M
Net Calls Change
+$1.61M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$72.6M +$1.17M +205,218 +2%
RM
2
Redpoint Management
California
$66.6M
IVMX
3
Institutional Venture Management XVI
California
$65.4M +$41.8K +7,345 +0.1%
IVMX
4
Institutional Venture Management XV
California
$65.4M +$41.8K +7,346 +0.1%
BlackRock
5
BlackRock
New York
$58.2M +$4.14M +726,956 +9%
NCPI
6
NewView Capital Partners I
California
$32.4M
Marshall Wace
7
Marshall Wace
United Kingdom
$28.8M +$12.7M +2,236,609 +99%
FCMV
8
Foresite Capital Management V
California
$25.9M +$4.11M +721,597 +22%
Millennium Management
9
Millennium Management
New York
$22.6M +$11.9M +2,090,833 +146%
OCM
10
Oaktree Capital Management
California
$21M
State Street
11
State Street
Massachusetts
$18.9M -$446K -78,406 -3%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$14.1M +$438K +76,928 +4%
Franklin Resources
13
Franklin Resources
California
$11.7M -$30.9K -5,424 -0.3%
N
14
Nuveen
North Carolina
$11.1M -$1.58M -277,378 -14%
Canada Pension Plan Investment Board
15
Canada Pension Plan Investment Board
Ontario, Canada
$10.1M
Renaissance Technologies
16
Renaissance Technologies
New York
$9.67M -$34.7K -6,100 -0.4%
D.E. Shaw & Co
17
D.E. Shaw & Co
New York
$9.47M +$1.16M +203,721 +16%
Citadel Advisors
18
Citadel Advisors
Florida
$9.23M +$3.83M +672,859 +88%
Morgan Stanley
19
Morgan Stanley
New York
$7.21M +$5.21M +915,928 +438%
JGC
20
J. Goldman & Co
New York
$7.21M +$3.17M +556,824 +98%
Northern Trust
21
Northern Trust
Illinois
$6.79M -$29K -5,095 -0.5%
Charles Schwab
22
Charles Schwab
California
$5.82M +$164K +28,764 +3%
BC
23
BIT Capital
Germany
$5.78M +$5.14M +902,130 New
CSS
24
Cubist Systematic Strategies
Connecticut
$5.64M +$3.21M +563,833 +178%
PFO
25
Pathstone Family Office
New Jersey
$5.13M

HIMS Hedge Fund Activity: Q4 2022 in Review

156 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Hims & Hers Health (HIMS) for Q4 2022, worth a combined $682M — up 6% from $643M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new HIMS positions and 22 closed out — a net gain of 6 holders — while 50 added to existing stakes and 42 trimmed.

The largest buyer was Marshall Wace, adding an estimated $12.7M. The largest seller was American Century Companies, exiting entirely with an estimated $8.33M sold.

  • 156 institutional investors held Hims & Hers Health (HIMS) as of Q4 2022, up from 154 in Q3 2022.
  • Funds reported $682M of Hims & Hers Health stock for Q4 2022, up 6% quarter-over-quarter.
  • 28 funds opened new Hims & Hers Health positions in Q4 2022 and 22 closed out, a net change of +6 holders.
  • The largest Hims & Hers Health buyer in Q4 2022 was Marshall Wace, an estimated $12.7M added.
  • The largest Hims & Hers Health seller in Q4 2022 was American Century Companies, an estimated $8.33M sold.

Based on aggregated 13F filings for Q4 2022.